# Prospective Observational Epidemiologic Study of Maraviroc's Safety

> **NCT00665561** · — · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 2500 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Maraviroc along with an optimized background antiretroviral drug regimen
- **DRUG:** Optimized background antiretroviral drug regimen without maraviroc

## Key facts

- **NCT ID:** NCT00665561
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-31
- **Primary completion:** 2019-02-14
- **Final completion:** 2019-02-14
- **Target enrollment:** 2500 (ACTUAL)
- **Last updated:** 2022-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665561, "Prospective Observational Epidemiologic Study of Maraviroc's Safety". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00665561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*